List of Excipients in API carbidopa, levodopa, and entacapone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing carbidopa, levodopa, and entacapone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | STALEVO | carbidopa, levodopa, and entacapone | 0078-0407 | CROSCARMELLOSE SODIUM | |
| Novartis Pharmaceuticals Corporation | STALEVO | carbidopa, levodopa, and entacapone | 0078-0407 | FERRIC OXIDE RED | |
| Novartis Pharmaceuticals Corporation | STALEVO | carbidopa, levodopa, and entacapone | 0078-0407 | FERRIC OXIDE YELLOW | |
| Novartis Pharmaceuticals Corporation | STALEVO | carbidopa, levodopa, and entacapone | 0078-0407 | GLYCERIN | |
| Novartis Pharmaceuticals Corporation | STALEVO | carbidopa, levodopa, and entacapone | 0078-0407 | HYPROMELLOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for carbidopa, levodopa, and entacapone
Excipient focus: CROSCARMELLOSE SODIUM
carbidopa, levodopa, and entacapone drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
carbidopa, levodopa, and entacapone drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
carbidopa, levodopa, and entacapone drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
carbidopa, levodopa, and entacapone drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
carbidopa, levodopa, and entacapone drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
carbidopa, levodopa, and entacapone drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
carbidopa, levodopa, and entacapone drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
carbidopa, levodopa, and entacapone drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
carbidopa, levodopa, and entacapone drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
carbidopa, levodopa, and entacapone drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
carbidopa, levodopa, and entacapone drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
carbidopa, levodopa, and entacapone drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | carbidopa, levodopa, and entacapone | 0078-0407 |
| Sandoz Inc | carbidopa, levodopa, and entacapone | 0781-5669 |
| Almatica Pharma LLC | carbidopa, levodopa, and entacapone | 52427-805 |
| >Company | >Ingredient | >NDC |
carbidopa, levodopa, and entacapone drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
